Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-20

Clinical Trial Update: Labetalol and Esmolol: Vital Signs and Post Operative Pain Management [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing the use of labetalol and esmolol for vital signs and postoperative pain management in laparoscopic surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esmolol (esmolol)
  • labetalol (labetalol hydrochloride)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Laparoscopic Surgery | Phase 4 | Status: COMPLETED | Results posted: 2020-02-20